It was reported that on (b)(6) 2024, a patient presented with grade 4 degenerative mitral regurgitation (mr) and posterior leaflet segment 2 (p2) prolapse and flail for a mitraclip procedure.One clip was implanted and the mr was reduced to grade 1.On (b)(6) 2024, a follow-up transthoracic echocardiogram (tte) displayed the same grade 1 mr and a stable and well seated device attachment.On (b)(6) 2024, a single leaflet device attachment (slda) and recurrent grade 3-4 mr was observed on ttr.Patient returned with heart failure [new york heart association (nyha) class iii].The clip remained attached to the anterior leaflet and detached from the posterior.On (b)(6) 2024, a second clip intervention was performed.There was no evidence of tissue injury.Two clips were implanted on the lateral and medial side of the slda clip.The mr was reduced to grade 1-1+ (mild residual result).
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar complaints reported from this lot.Based on available information, the reported slda was likely due to patient anatomy.The reported recurrent mr was a cascading event of the reported slda.The reported heart failure is likely a cascading event of the reported recurrent mr.The reported patient effects of mitral regurgitation and heart failure, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported unexpected medical intervention and hospitalization were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|